Becky Davidson is a market access and commercialization strategist with deep expertise in competitive spaces, particularly 505(b)(2), biosimilars, and complex generics. She is a recognized thought leader in aligning regulatory, access, and payer strategies to maximize product value and uptake, especially for launches in crowded or highly competitive markets. Becky leads strategy development around inpatient and outpatient coding and reimbursement, supporting formulary access and launch success. She also works closely with cross-functional client teams, helping them upskill on complex market access issues to navigate new therapeutic areas and launch models effectively. Prior to Avalere, Becky managed research and special projects within Mylan Pharmaceuticals' Global Policy group. In this role, she supported global generic access initiatives and advanced policy strategies aligned with corporate goals, particularly around infectious diseases and access. She also led the development of key internal proof points to articulate the Mylan access story, synthesizing data from across the organization to support strategic engagement with policy stakeholders. Earlier in her career, Becky advised healthcare providers, consumer groups, and policymakers on antitrust and competition policy in healthcare, working alongside a former Federal Trade Commission policy director. She holds a BS in Resource Economics from the University of Massachusetts Amherst and an MBA from Georgetown University.
